Cellebrite Di Ltd. - (CLBT) closed at $12.45 on November 6, 2026, up 0.6% from the previous close, on volume of 1,446,612 shares (30-day average 1,780,862).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 14, 2026 | Ratio Call Spread 1 by 2 | 18-Dec-2610 : 15[2x] C | 750 |
| 2-2 | The next 1 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Cellebrite Appoints Rogerio Rizzi Executive Vice President of Corporate Strategy and Development
PRNewswire (Thu, 5-Nov 8:30 AM ET)
PRNewswire (Wed, 21-Oct 8:31 AM ET)
Cellebrite to Report Third-Quarter 2026 Financial Results on November 12, 2026
PRNewswire (Tue, 20-Oct 8:30 AM ET)
PRNewswire (Thu, 15-Oct 10:02 AM ET)
Newsfile (Thu, 8-Oct 4:10 PM ET)
Kaplan Fox is Investigating Cellebrite DI Ltd. (CLBT) for Investors Who Suffered Losses
Newsfile (Tue, 6-Oct 6:25 PM ET)
Kaplan Fox Urges Investors of Cellebrite DI Ltd. (CLBT) with Losses to Contact the Firm
Newsfile (Fri, 2-Oct 2:15 PM ET)
Kaplan Fox Reminds Investors of Cellebrite DI Ltd. (CLBT) of an Ongoing Securities Investigation
Newsfile (Wed, 30-Sep 8:41 AM ET)
Newsfile (Mon, 28-Sep 8:06 AM ET)
Newsfile (Thu, 24-Sep 4:20 PM ET)
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Cellebrite Di Ltd. - trades on the NASDAQ stock market under the symbol CLBT.
As of November 6, 2026, CLBT stock price climbed to $12.45 with 1,446,612 million shares trading.
CLBT has a beta of 0.87, meaning it tends to be less sensitive to market movements. CLBT has a correlation of 0.02 to the broad based SPY ETF.
CLBT has a market cap of $2.98 billion. This is considered a Mid Cap stock.
Last quarter Cellebrite Di Ltd. - reported $131 million in Revenue and $.11 earnings per share. This fell short of revenue expectation by $-934,488 and met earnings estimates .
In the last 3 years, CLBT traded as high as $26.30 and as low as $7.15.
The top ETF exchange traded funds that CLBT belongs to (by Net Assets): IEFA, SCZ, WCLD, EIS, SMLF.
CLBT has underperformed the market in the last year with a return of -18.4%, while the SPY ETF gained +10.8%. In the last 3 month period, CLBT fell short of the market, returning -19.5%, while SPY returned -4.1%. However, in the most recent 2 weeks CLBT has outperformed the stock market by returning +2.9%, while SPY returned -3.2%.
CLBT support price is $12.05 and resistance is $12.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLBT shares will trade within this expected range on the day.
